Comparison of triple helix formation by polypurine versus polypyrimidine oligodeoxynucleotides when conjugated to a DNA intercalator

Journal of Experimental Therapeutics and Oncology

Volumn 1, Issue 3, 1996, Pages 177-185

  Orson, F M ^a,b   Klysik, J ^a,b   Glass, G A ^a   Kinsey, B M ^a,b  

^a Veterans Affairs Medical Center

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Acridine; Magnesium; Potassium; Triple helix

Indexed keywords

BUFFER; INTERCALATING AGENT; INTERLEUKIN 2; MAGNESIUM; OLIGONUCLEOTIDE; PURINE DERIVATIVE; PYRIMIDINE DERIVATIVE;

ARTICLE; CHEMISTRY; COMPARATIVE STUDY; CONFORMATION; GENETICS; KINETICS; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PH; POLYACRYLAMIDE GEL ELECTROPHORESIS; TEMPERATURE;

BASE SEQUENCE; BUFFERS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HYDROGEN-ION CONCENTRATION; INTERCALATING AGENTS; INTERLEUKIN-2; KINETICS; MAGNESIUM; MOLECULAR SEQUENCE DATA; NUCLEIC ACID CONFORMATION; OLIGONUCLEOTIDES; PURINES; PYRIMIDINES; TEMPERATURE;

EID: 0030132031     PISSN: 13594117     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Mahler LJ, Wold B, Dervan PB. Inhibition of DNA binding proteins by oligonucleotide-directed triple helix formation. Science 245: 725-730, 1989.
2. Hélène C. Rational design of sequence-specific oncogene inhibitors based on antisense and antigene oligonucleotides. J Cancer 27: 1466-1471, 1991.
3. Gee JE, Miller DM. Structure and applications of intermolecular DNA triplexes. Am J Med Sci 304: 366-372, 1992.
4. Thuong NT, Hélène C. Sequence-specific recognition and modification of double-helical DNA by oligonucleotides. Angew Chem Int Ed Engl 32: 666-690, 1993.
5. Scanlon KJ, Ohta Y, Ishida H, et al. Oligonucleotide-mediated modulation of mammalian gene expression. FASEB J 9: 1288-1296, 1995.
6. Dervan PB. In: Cohan JS, (ed.) Oligodoxynucleotides: Antisense Inhibitors of Gene Expression. Boca Raton, FL: CRC Press, Inc., 197-210, 1989.
7. Grigoriev M, Praseuth D, Robin P, et al. A triple helix-forming oligonucleotide-intercalator conjugate acts as a transcriptional repressor via inhibition of NFkB binding to interleukin-2 receptor alpha-regulatory sequence. J Biol Chem 267: 3389-3395, 1992.
8. Havre PA, Gunther EJ, Gasparro FP, Glazer PM. Targeted mutagenesis of DNA using triple helix-forming oligonucleotides linked to psoralen. Proc Natl Acad Sci (USA) 90: 7879-7883, 1993.
9. Orson FM, Kinsey BM, McShan WM. Linkage structures strongly influence the binding cooperativity of DNA intercalators conjugated to triplex forming oligonucleotides. Nucleic Acids Res 22: 479-484, 1994.
10. Beal PA, Dervan PB. Second structural motif for recognition of DNA by oligonucleotide-directed triple helix formation. Science 251: 1360-1363, 1991.
11. Durland RE, Kessler DJ, Hogan ME. In: Wickstrom E, (ed.) Prospects for antisense nucleic acid therapy of cancer and AIDS. New York: Wiley-Liss, 1992.
12. Felsenfeld G, Davies DR, Rich A. Formation of a three-stranded polynucleotide molecule. J Am Chem Soc 79: 2023-2024, 1957.
13. Moser HE, Dervan PB. Sequence-specific cleavage of double helical DNA by triple helix formation. Science 238: 645-650, 1987.
14. Orson FM, Thomas DW, McShan WM, Kessler DJ, Hogan ME. Oligonucleotide inhibition of IL2Ra mRNA transcription by promoter region collinear triplex formation in lymphocytes. Nucleic Acids Res 19: 3435-3441, 1991.
15. Brown T, Brown DJ. In: Eckstein, F. (ed.). Oligonucleotide and analogues: A practical approach. New York: IRL Press, 1-24, 1991.
16. Orson FM. Photodocumentation of UV shadowing with DNA gels. BioTechniques 16: 592-596, 1994.
17. Cooney M, Czernusezewicz G, Postel EH, Flint SJ, Hogan ME. Site-specific oligonucleotide binding represses transcription of the human c-myc gene in vitro. Science 241: 456-459, 1988.
18. McShan WM, Rossen RD, Laughter AH, et al. Inhibition of transcription of HIV-1 in infected human cells by oligodeoxynucleotides designed to form DNA triple helices. J Biol Chem 267: 5712-5721, 1992.
19. Noonberg SB, Francois J-C, Garestier T, Hélène C. Effect of competing self-structure on triplex formation with purine-rich oligodeoxynucleotides containing GA repeats. Nucleic Acids Res 23: 1956-1963, 1995.
20. Sen D, Gilbert W. A sodium-potassium switch in the formation of four-stranded G4-DNA. Nature 344: 410-414, 1990.
21. Lee JS. The stability of polypurine tetraplexes in the presence of mono- and divalent cations. Nucleic Acids Res 18: 6057-6060, 1990.
22. Jin RZ, Breslauer KJ, Jones RA, Gaffney BL. Tetraplex formation of a guanine-containing nonameric DNA fragment. Science 250: 543-546, 1990.
23. Borisova OF, Shchyolkina AK, Timofeev EN, Florentiev VL. Evidence for the tetraplex structure of the d(GT) in repetitive sequences in solution. Febs Lett 306: 140-142, 1992.
24. Rippe K, Fritsch V, Westhof E, Jovin TM. Alternating d(G-A) sequences from a parallel-stranded DNA homoduplex. EMBO 11: 3777-3786, 1992.
25. Cheng AJ, Van Dyke MW. Monovalent cation effects on intermolecular purine-purine-pyrimidine triple-helix formation. Nucleic Acids Res 21: 5630-5635, 1993.
26. Laughlan G, Murchie AIH, Normal DG, et al. The high-resolution crystal structure of a parallel-stranded guanine tetraplex. Science 265: 520-524, 1994.
27. Milligan JF, Krawcyzk SH, Wadwani S, Matteuci MD. An antiparallel triple helix motif with oligodeoxynucleotides containing 2′-deoxyguanosine and 7-deaza-2′-deoxyxanthosine. Nucleic Acids Res 21: 327-333, 1993.
28. Singleton SF, Dervan PB. Equilibrium association constants for oligonucleotide-directed triple helix formation at single DNA sites: Linkage to cation valence and concentration. Biochemistry 32: 13171-13179, 1993.
29. Olivas WM, Maher LJ. Competitive triplex/quadriplex equilibria involving guanine-rich oligonucleotides. Biochemistry 34: 278-284, 1995.
30. Maher LJ, Dervan PB, Wold BJ. Kinetic analysis of oligodeoxyribonucleotide-directed triple-helix formation on DNA. Biochemistry 29: 8820-8826, 1990.
31. Rougee M, Faucon B, Mergny JL, et al. Kinetics and thermodynamics of triple-helix formation: effects of ionic strength and mismatches. Biochemistry 31: 9269-9278, 1992.
32. Bates PJ, Dosanjh HS, Kumar S, Jenkins TC, Laughton CA, Neidle S. Detection and kinetic studies of triplex formation by oligodeoxynucleotides using real-time biomolecular interaction analysis (BIA). Nucleic Acids Res 23: 3627-3632, 1995.
33. Yoon K, Hobbs CA, Koch J, Sardano M, Kutny R, Weis AL. Elucidation of the sequence-specific third-strand recognition of four Watson-Crick base pairs in a pyrimidine triple helix motif: T·AT, C·GC, T·CG, and T·TA. Proc Natl Acad Sci USA 89: 3840-3844, 1992.
34. Huang C-C, Nguyen KD, Martinez R, Edwards CA. Triple-helix formation is compatible with an adjacent DNA-protein complex. Biochemistry 31: 993-998, 1992.
35. Fossella JA, Kim YJ, Shih H, Richards EG, Fresco JR. Relative specificities in binding triplex motif. Nucleic Acids Res 21: 4511-4515, 1993.
36. Olivas WM, Maher U. DNA recognition by alternate strand triple helix formation: Affinities of oligonucleotides for a site in the human P53 gene. Biochemistry 33: 983-991, 1994.
37. Wagner RW. Gene inhibition using antisense oligodeoxynucleotides. Nature 372: 333-335, 1994.
38. Kim HG, Miller DM. Inhibition of in vitro transcription by a triplex-forming oligonucleotide targeted to human c-myc P2 promoter. Biochem 34: 8165-8171, 1995.
39. Greenberg WA, Dervan PB. Energetics of formation of sixteen triple helical complexes which vary at a single position within a purine motif. J Am Chem Soc 177: 5016-5022, 1995.
40. Vasquez KM, Wensel TG, Hogan ME, Wilson JH. High-affinity triple helix formation by synthetic oligonucleotides at a site within a selectable mammalian gene. Biochem 34: 7243-7251, 1995.
41. Hampel KJ, Crosson P, Lee JS. Polyamines favor DNA triplex formation at neutral pH. Biochemistry 30: 4455-4459, 1991.
42. Musso M, Van Dyke MW. Polyamine effects on purine-purine-pyrimidine triple helix formation by phosphodiester and phosphorothioate oligodeoxynucleotides. Nucleic Acids Res 23: 2320-2327, 1995.